Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.

作者: Erhan Tenekecioglu , Patrick W. Serruys , Yoshinobu Onuma , Ricardo Costa , Daniel Chamié

DOI: 10.1016/J.JCIN.2017.03.015

关键词: Coronary arteriesSurgeryBioresorbable vascular scaffoldOptical coherence tomographyNuclear medicineSirolimusMedicineInterquartile rangeMicrofiberScaffoldAngiography

摘要: Abstract Objectives The primary objective of this study was to evaluate the safety and effectiveness Mirage (Manli Cardiology, Singapore) bioresorbable microfiber sirolimus-eluting scaffold compared with Absorb (Abbott Vascular, Santa Clara, California) vascular in treatment stenotic target lesions located native coronary arteries, ranging from ≥2.25 to ≤4.0 mm diameter. Secondary objectives were establish medium-term safety, effectiveness, performance device. Background current generation scaffolds has several limitations, such as thick square struts large footprints that preclude their deep embedment into vessel wall, resulting protrusion lumen microdisturbance flow. is designed address these concerns. Methods In prospective, single-blind trial, 60 patients randomly allocated a 1:1 ratio or an scaffold. clinical endpoints assessed at 30 days 6 12 months. In-device angiographic late loss months quantified. optical coherence tomographic post–scaffold implantation Results Median post-procedural in-scaffold minimal luminal diameters devices 2.38 (interquartile range [IQR]: 2.06 2.62 mm) 2.55 (IQR: 2.26 2.71 mm), respectively; effect size (d) was −0.29. At months, median not statistically different (1.90 [IQR: 1.57 2.31 mm] vs. 2.29 1.74 2.51 mm], d = −0.36). 12-month follow-up, 0.37 mm 0.08 0.72 0.23 0.15 0.37 respectively (d = 0.20). On tomography, diameter stenosis 11.2 ± 7.1%, which increased 27.4 12.4% 6 months remained stable (31.8 12.9%) 1 year, whereas 8.4 6.6%, 16.6 8.9% (21.2 9.9%) 1-year follow-up (Mirage Absorb: dpost-procedure = 0.41, d6 months = 1.00, d12 0.92). Angiographic significantly between groups (28.6% 21.0% 40.7%] for Mirage, 18.2% 13.1% 31.6%] Absorb, d = 0.39). Device- patient-oriented composite comparable 2 groups. Conclusions devices, although on angiography tomography higher than Absorb. technique suboptimal both future trials should incorporate guidance allow optimal appropriate assessment new technology, considering novel mechanical properties Mirage.

参考文章(15)
Patrick W. Serruys, Takashi Muramatsu, Shimpei Nakatani, Robert-Jan van Geuns, Bernard de Bruyne, Dariusz Dudek, Evald Christiansen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian Meredith, Hector M. Garcia-Garcia, Susan Veldhof, Richard Rapoza, John A. Ormiston, Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold JACC: Cardiovascular Interventions. ,vol. 7, pp. 1400- 1411 ,(2014) , 10.1016/J.JCIN.2014.06.016
Alessio Mattesini, Gioel G. Secco, Gianni Dall'Ara, Matteo Ghione, Juan C. Rama-Merchan, Alessandro Lupi, Nicola Viceconte, Alistair C. Lindsay, Ranil De Silva, Nicolas Foin, Toru Naganuma, Serafina Valente, Antonio Colombo, Carlo Di Mario, ABSORB Biodegradable Stents Versus Second-Generation Metal Stents JACC: Cardiovascular Interventions. ,vol. 7, pp. 741- 750 ,(2014) , 10.1016/J.JCIN.2014.01.165
Stefan Verheye, John A. Ormiston, James Stewart, Mark Webster, Elias Sanidas, Ricardo Costa, J. Ribamar Costa, Daniel Chamie, Andrea S. Abizaid, Ibraim Pinto, Lynn Morrison, Sara Toyloy, Vinayak Bhat, John Yan, Alexandre Abizaid, A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. Jacc-cardiovascular Interventions. ,vol. 7, pp. 89- 99 ,(2014) , 10.1016/J.JCIN.2013.07.007
Yoshinobu Onuma, Dariusz Dudek, Leif Thuesen, Mark Webster, Koen Nieman, Hector M. Garcia-Garcia, John A. Ormiston, Patrick W. Serruys, Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. Jacc-cardiovascular Interventions. ,vol. 6, pp. 999- 1009 ,(2013) , 10.1016/J.JCIN.2013.05.017
Robert-Jan van Geuns, Bernard de Bruyne, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian Meredith, Cecile Dorange, Susan Veldhof, Karine Miquel Hebert, Richard Rapoza, John A. Ormiston, Patrick W. Serruys, Yoshinobu Onuma, Hector M. Garcia-Garcia, Takashi Muramatsu, Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. Eurointervention. ,vol. 9, pp. 1271- 1284 ,(2014) , 10.4244/EIJV9I11A217
Juan M. Jiménez, Peter F. Davies, Hemodynamically Driven Stent Strut Design Annals of Biomedical Engineering. ,vol. 37, pp. 1483- 1494 ,(2009) , 10.1007/S10439-009-9719-9
Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Pieter C. Smits, Jacques Koolen, Bernard Chevalier, Bernard de Bruyne, Leif Thuesen, Dougal McClean, Robert-Jan van Geuns, Stephan Windecker, Robert Whitbourn, Ian Meredith, Cecile Dorange, Susan Veldhof, Karine Miquel Hebert, Krishnankutty Sudhir, Hector M. Garcia-Garcia, John A. Ormiston, Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging Outcomes Journal of the American College of Cardiology. ,vol. 58, pp. 1578- 1588 ,(2010) , 10.1016/J.JACC.2011.05.050
Donald E Cutlip, Stephan Windecker, Roxana Mehran, Ashley Boam, David J Cohen, Gerrit-Anne van Es, P Gabriel Steg, Marie-angèle Morel, Laura Mauri, Pascal Vranckx, Eugene McFadden, Alexandra Lansky, Martial Hamon, Mitchell W Krucoff, Patrick W Serruys, None, Clinical End Points in Coronary Stent Trials A Case for Standardized Definitions Circulation. ,vol. 115, pp. 2344- 2351 ,(2007) , 10.1161/CIRCULATIONAHA.106.685313
Jeroen J Bax, Helmut Baumgartner, Claudio Ceconi, Veronica Dean, Robert Fagard, Christian Funck-Brentano, David Hasdai, Arno Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Cyril Moulin, Bogdan A Popescu, Zeljko Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Joao Morais, Carlos Aguiar, Wael Almahmeed, David O Arnar, Fabio Barili, Kenneth D Bloch, Ann F Bolger, Hans Erik Botker, Biykem Bozkurt, Raffaele Bugiardini, Christopher Cannon, James de Lemos, Franz R Eberli, Edgardo Escobar, Mark Hlatky, Stefan James, Karl B Kern, David J Moliterno, Christian Mueller, Aleksandar N Neskovic, Burkert Mathias Pieske, Steven P Schulman, Kathryn A Taubert, Pascal Vranckx, Daniel R Wagner, Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Maarten L Simoons, Bernard R Chaitman, Harvey D White, Hugo A Katus, Fred S Apple, Bertil Lindahl, David A Morrow, Peter M Clemmensen, Per Johanson, Hanoch Hod, Richard Underwood, Robert O Bonow, Fausto Pinto, Raymond J Gibbons, Keith A Fox, Dan Atar, L Kristin Newby, Marcello Galvani, Christian W Hamm, Barry F Uretsky, Ph Gabriel Steg, William Wijns, Jean-Pierre Bassand, Phillippe Menasche, Jan Ravkilde, E Magnus Ohman, Elliott M Antman, Lars C Wallentin, Paul W Armstrong, James L Januzzi, Markku S Nieminen, Mihai Gheorghiade, Gerasimos Filippatos, Russell V Luepker, Stephen P Fortmann, Wayne D Rosamond, Dan Levy, David Wood, Sidney C Smith, Dayi Hu, Jose-Luis Lopez-Sendon, Rose Marie Robertson, Douglas Weaver, Alfred A Bove, Alexander N Parkhomenko, Elena J Vasilieva, Shanti Mendis, ESC Committee for Practice Guidelines (CPG, None, Third universal definition of myocardial infarction Journal of the American College of Cardiology. ,vol. 126, pp. 2551- 2567 ,(2012) , 10.1093/EURHEARTJ/EHS184
Fumiyuki Otsuka, Erica Pacheco, Laura E.L. Perkins, Jennifer P. Lane, Qing Wang, Marika Kamberi, Michael Frie, Jin Wang, Kenichi Sakakura, Kazuyuki Yahagi, Elena Ladich, Richard J. Rapoza, Frank D. Kolodgie, Renu Virmani, Long-Term Safety of an Everolimus-Eluting Bioresorbable Vascular Scaffold and the Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model Circulation: Cardiovascular Interventions. ,vol. 7, pp. 330- 342 ,(2014) , 10.1161/CIRCINTERVENTIONS.113.000990